Allele Biotechnology Pharmaceuticals Inc

General

Total Cases3

Active Cases1

Patents--

CourtsS.D. California S.D. New York

TypeOperating Company

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
10/21/24	Allele Biotechnology Pharmaceuticals Inc v. Regeneron Pharmaceuticals Inc 7:20-CV-08255 ( S.D. NY )	Appeal Record Sent to USCA (Electronic File). Certified Indexed record on Appeal Electronic Files for [200] Notice of Appeal to the Federal Circuit, filed by Regeneron Pharmaceuticals, Inc. were transmitted to the U.S. Court of Appeals. (km) (Entered: 10/21/2024)
10/21/24	Allele Biotechnology Pharmaceuticals Inc v. Regeneron Pharmaceuticals Inc 7:20-CV-08255 ( S.D. NY )	Transmission of Notice of Appeal and Certified Copy of Docket Sheet to US Court of Appeals re: [200] Notice of Appeal to the Federal Circuit.(km) (Entered: 10/21/2024)
10/18/24	Allele Biotechnology Pharmaceuticals Inc v. Regeneron Pharmaceuticals Inc 7:20-CV-08255 ( S.D. NY )	LETTER MOTION for Leave to File Motion for Stay pending Regeneron's appeal to the Federal Circuit addressed to Judge Philip M. Halpern from Michael Morin dated October 18, 2024. Document filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # [1] Exhibit A - Unpublished Authority).(Morin, Michael) (Entered: 10/18/2024)
10/18/24	Allele Biotechnology Pharmaceuticals Inc v. Regeneron Pharmaceuticals Inc 7:20-CV-08255 ( S.D. NY )	NOTICE OF APPEAL TO THE FEDERAL CIRCUIT from [66] Order on Motion to Dismiss,,, [140] Stipulation and Order,,, [119] Order, [197] Memorandum & Opinion,,. Form 7 and Form 22 are due within 14 days. Document filed by Regeneron Pharmaceuticals, Inc.. Filing fee $ 605.00, receipt number ANYSDC-30063610..(Morin, Michael) (Entered: 10/18/2024)
10/04/24	Allele Biotechnology Pharmaceuticals Inc v. Regeneron Pharmaceuticals Inc 7:20-CV-08255 ( S.D. NY )	ORDER granting [184] Letter Motion to Seal Application granted. The following documents shall be placed under seal: Memorandum of Law in Support of Defendant'sMotion for Partial Summary Judgment and inOpposition to Plaintiff's Motion for Partial Summary Judgment (Doc. 195); Reply in Support of Defendant's Motion for Partial Summary Judgment (Doc. 193);Joint Local Rule 56.1 Statement of Material Facts (Doc. 190); and Exhibits 2-10, 14-16, 24-28, 33, 36, 38, and 41-43 of the Declaration of Michelle L. Ernst (Doc. 196). The Clerk of Court is directed to terminate the motion at Doc. 184. SO ORDERED. (Signed by Judge Philip M. Halpern on 10/4/2024) (jca) (Entered: 10/04/2024) ORDER granting [184] Letter Motion to Seal Application granted. The following documents shall be placed under seal: Memorandum of Law in Support of Defendant'sMotion for Partial Summary Judgment and inOpposition to Plaintiff's Motion for Partial Summary Judgment (Doc. 195); Reply in Support of Defendant's Motion for Partial Summary Judgment (Doc. 193);Joint Local Rule 56.1 Statement of Material Facts (Doc. 190); and Exhibits 2-10, 14-16, 24-28, 33, 36, 38, and 41-43 of the Declaration of Michelle L. Ernst (Doc. 196). The Clerk of Court is directed to terminate the motion at Doc. 184. SO ORDERED. (Signed by Judge Philip M. Halpern on 10/4/2024) (jca) (Entered: 10/04/2024)
10/04/24	Allele Biotechnology Pharmaceuticals Inc v. Regeneron Pharmaceuticals Inc 7:20-CV-08255 ( S.D. NY )	MEMO ENDORSEMENT on re: [177] LETTER MOTION to Seal Summary Judgment Filings addressed to Judge Philip M. Halpern from Christopher G. Hanewicz dated July 19, 2024. filed by Allele Biotechnology and Pharmaceuticals, Inc. ENDORSEMENT Application granted. The following documents shall be placed under seal: The Memorandum of Law in support of Plaintiff's Motion for Partial Summary Judgment (Doc. 177); Plaintiff's Opposition to Defendant's Motion for Summary Judgment and Reply in Support of Plaintiff's Motion for Summary Judgment (Doc. 182); and Exhibits 1-8, 10, and 14 to the Declaration of David L. Anstaett in Support of Plaintiff's Motion for Partial Summary Judgment (Doc. 182). The Clerk of Court is directed to terminate the motion at Doc. 177. SO ORDERED. (Signed by Judge Philip M. Halpern on 10/4/2024) (jca) (Entered: 10/04/2024) MEMO ENDORSEMENT on re: [177] LETTER MOTION to Seal Summary Judgment Filings addressed to Judge Philip M. Halpern from Christopher G. Hanewicz dated July 19, 2024. filed by Allele Biotechnology and Pharmaceuticals, Inc. ENDORSEMENT Application granted. The following documents shall be placed under seal: The Memorandum of Law in support of Plaintiff's Motion for Partial Summary Judgment (Doc. 177); Plaintiff's Opposition to Defendant's Motion for Summary Judgment and Reply in Support of Plaintiff's Motion for Summary Judgment (Doc. 182); and Exhibits 1-8, 10, and 14 to the Declaration of David L. Anstaett in Support of Plaintiff's Motion for Partial Summary Judgment (Doc. 182). The Clerk of Court is directed to terminate the motion at Doc. 177. SO ORDERED. (Signed by Judge Philip M. Halpern on 10/4/2024) (jca) (Entered: 10/04/2024)
10/04/24	Allele Biotechnology Pharmaceuticals Inc v. Regeneron Pharmaceuticals Inc 7:20-CV-08255 ( S.D. NY )	OPINION & ORDER re: [179] MOTION for Summary Judgment . filed by Allele Biotechnology and Pharmaceuticals, Inc., [185] MOTION for Partial Summary Judgment . filed by Regeneron Pharmaceuticals, Inc..For the foregoing reasons, Defendants motion for summary judgment is DENIED and Plaintiff's motion for summary judgment is GRANTED. The Clerk of Court is respectfully directed to terminate the motions pending at Doc. 177, Doc. 185, and Doc. 192. The parties are directed to file, by November 4, 2024, the pretrial materials set forth in Rules 6(A) and 6(B) of the Court's Individual Practices in Civil Cases. SO ORDERED. (Signed by Judge Philip M. Halpern on 10/4/2024) (jca) (Entered: 10/04/2024) OPINION & ORDER re: [179] MOTION for Summary Judgment . filed by Allele Biotechnology and Pharmaceuticals, Inc., [185] MOTION for Partial Summary Judgment . filed by Regeneron Pharmaceuticals, Inc..For the foregoing reasons, Defendants motion for summary judgment is DENIED and Plaintiff's motion for summary judgment is GRANTED. The Clerk of Court is respectfully directed to terminate the motions pending at Doc. 177, Doc. 185, and Doc. 192. The parties are directed to file, by November 4, 2024, the pretrial materials set forth in Rules 6(A) and 6(B) of the Court's Individual Practices in Civil Cases. SO ORDERED. (Signed by Judge Philip M. Halpern on 10/4/2024) (jca) (Entered: 10/04/2024)
07/19/24	Allele Biotechnology Pharmaceuticals Inc v. Regeneron Pharmaceuticals Inc 7:20-CV-08255 ( S.D. NY )	*SELECTED PARTIESDECLARATION of Michelle L. Ernst in Support re: 185 MOTION for Partial Summary Judgment .. Document filed by Regeneron Pharmaceuticals, Inc., Allele Biotechnology and Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 2 - Klinman Expert Rep, # 2 Exhibit 3 - Baum Dep Tr, # 3 Exhibit 4 - Poats Dep Ex 7, # 4 Exhibit 5 - Poats Dep Ex 5, # 5 Exhibit 6 - Poats Dep Tr, # 6 Exhibit 7 - Hussain Dep Tr, # 7 Exhibit 8 - Wang Dep Tr, # 8 Exhibit 9 - ALLELE-RP-0012659, # 9 Exhibit 10 - ALLELE-RP-0019354, # 10 Exhibit 14 - ALLELE-RP-0019639, # 11 Exhibit 15 - ALLELE-RP-0015824, # 12 Exhibit 16 - Jimenez Expert Rep, # 13 Exhibit 24 - ALLELE-RP-0029766, # 14 Exhibit 25 - ALLELE-RP-0001232, # 15 Exhibit 26 - Jarosz Responsive Expert Rep [CORRECTED], # 16 Exhibit 27 - Campbell Expert Rep, # 17 Exhibit 28 - Campbell Dep Tr, # 18 Exhibit 33 - Malackowski Opening Expert Rep, # 19 Exhibit 36 - Fulton Dep Tr, # 20 Exhibit 38 - Ravi Dep Tr, # 21 Exhibit 41 - Baum Dep Ex 11, # 22 Exhibit 42 - Pre-Motion Conference Tr, # 23 Exhibit 43 - Baum Declaration)Motion or Order to File Under Seal: 184 .(Ernst, Michelle) (Entered: 07/19/2024) SELECTED PARTIES*DECLARATION of Michelle L. Ernst in Support re: 185 MOTION for Partial Summary Judgment .. Document filed by Regeneron Pharmaceuticals, Inc., Allele Biotechnology and Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 2 - Klinman Expert Rep, # 2 Exhibit 3 - Baum Dep Tr, # 3 Exhibit 4 - Poats Dep Ex 7, # 4 Exhibit 5 - Poats Dep Ex 5, # 5 Exhibit 6 - Poats Dep Tr, # 6 Exhibit 7 - Hussain Dep Tr, # 7 Exhibit 8 - Wang Dep Tr, # 8 Exhibit 9 - ALLELE-RP-0012659, # 9 Exhibit 10 - ALLELE-RP-0019354, # 10 Exhibit 14 - ALLELE-RP-0019639, # 11 Exhibit 15 - ALLELE-RP-0015824, # 12 Exhibit 16 - Jimenez Expert Rep, # 13 Exhibit 24 - ALLELE-RP-0029766, # 14 Exhibit 25 - ALLELE-RP-0001232, # 15 Exhibit 26 - Jarosz Responsive Expert Rep [CORRECTED], # 16 Exhibit 27 - Campbell Expert Rep, # 17 Exhibit 28 - Campbell Dep Tr, # 18 Exhibit 33 - Malackowski Opening Expert Rep, # 19 Exhibit 36 - Fulton Dep Tr, # 20 Exhibit 38 - Ravi Dep Tr, # 21 Exhibit 41 - Baum Dep Ex 11, # 22 Exhibit 42 - Pre-Motion Conference Tr, # 23 Exhibit 43 - Baum Declaration)Motion or Order to File Under Seal: 184 .(Ernst, Michelle) (Entered: 07/19/2024)
07/19/24	Allele Biotechnology Pharmaceuticals Inc v. Regeneron Pharmaceuticals Inc 7:20-CV-08255 ( S.D. NY )	*SELECTED PARTIES* MEMORANDUM OF LAW in Support re: 185 MOTION for Partial Summary Judgment . // CORRECTED Memorandum of Law in Support of Defendant's Motion for Partial Summary Judgment and in Opposition to Plaintiff's Motion for Partial Summary Judgment. Document filed by Regeneron Pharmaceuticals, Inc., Allele Biotechnology and Pharmaceuticals, Inc.. Motion or Order to File Under Seal: 184 .(Morin, Michael) (Entered: 07/19/2024) *SELECTED PARTIES* MEMORANDUM OF LAW in Support re: 185 MOTION for Partial Summary Judgment . // CORRECTED Memorandum of Law in Support of Defendant's Motion for Partial Summary Judgment and in Opposition to Plaintiff's Motion for Partial Summary Judgment. Document filed by Regeneron Pharmaceuticals, Inc., Allele Biotechnology and Pharmaceuticals, Inc.. Motion or Order to File Under Seal: 184 .(Morin, Michael) (Entered: 07/19/2024)
07/19/24	Allele Biotechnology Pharmaceuticals Inc v. Regeneron Pharmaceuticals Inc 7:20-CV-08255 ( S.D. NY )	REPLY MEMORANDUM OF LAW in Support re: 185 MOTION for Partial Summary Judgment . [REDACTED]. Document filed by Regeneron Pharmaceuticals, Inc...(Morin, Michael) (Entered: 07/19/2024)